Windham Venture Partners

Founded 2006
Founders Adam Fine Roger Fine

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 38
Average round size
info
The average size of a deal this fund participated in
$23M
Portfolio companies 26
Rounds per year 2.53
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.37
Exits 3
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Medical
  • Health Diagnostics
Summary

In 2006 was created Windham Venture Partners, which is appeared as VC. The company was established in North America in United States. The main office of represented VC is situated in the New York.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline Neotract, CVRx, Earlens Corporation Among the most successful fund investment fields, there are SaaS, Manufacturing.

The higher amount of exits for fund were in 2019. Opposing the other organizations, this Windham Venture Partners works on 19 percentage points less the average amount of lead investments. The fund is generally included in 2-6 deals every year. The typical startup value when the investment from Windham Venture Partners is 50-100 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this VC is 14 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2019.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Windham Venture Partners, startups are often financed by Versant Ventures, Split Rock Partners, Morgenthaler Ventures. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures HC, Vertex Ventures, Versant Ventures. In the next rounds fund is usually obtained by New Enterprise Associates, Vertex Ventures HC, Versant Ventures.

The current fund was established by Adam Fine, Roger Fine. We also calculated 3 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Windham Venture Partners:
Typical Co-investors
Windham Venture Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Windham Venture Partners:

Funds with similar focus

Funds from United States, New York
Funds with similar focus located in United States, New York:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Myeloma Investment Fund United States, Brookline
Zhejiang Silicon Paradise Asset Management Group China, Hangzhou
Bright Technologies Fund Switzerland, Lugano
Blue Chip Capital -
Native Angels Network India, New Delhi
Synergia Capital Partners Netherlands, Veenendaal
Japan-Israel Hi-Tech Ventures -
Belt Road Capital Management Cambodia, Phnom Penh
BioTex Finance United States, Houston
Tallwood Venture Capital United States, Menlo Park
Bios Partners United States, Fort Worth
Medical Technologies Innovation Asia China, Hong Kong Island
ZJ Innopark (Zhangjiang Hi-Tech Park) China, Shanghai
Brooke Private Equity Advisors United States, Boston
Tech Wildcatters United States, Dallas
Stage 1 Ventures United States, Waltham
High Peak Capital -
Vulcan United States, Seattle
Galois Capital United States, San Francisco

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Upward Health

n/a
02 Mar 2021 United States, Providence

Personal Genome Diagnostics

Analytics
Bioinformatics
Biotechnology
Genetics
Health Diagnostics
Medical
1
$103M10 Feb 2021 United States, Baltimore

Valera Health

Analytics
Health Care
Hospital
n/a
$3M03 Feb 2021 United States, New York

Delfi Diagnostics

Biotechnology
Health Care
Health Diagnostics
1
$100M12 Jan 2021 United States, Baltimore

ControlRad Systems

Biotechnology
Developer Platform
Health Care
Medical Device
1
$12M11 Sep 2020 United States, " United States"}

HelpAround Medical

Health Care
Health Diagnostics
mHealth
Pharmaceutical
1
$6M21 Jan 2020 United States, Bethesda

ChromaCode

Biotechnology
Health Care
Health Diagnostics
1
$28M17 Dec 2019 United States, Carlsbad

Science Exchange

Consulting
Outsourcing
n/a
16 Oct 2019 United States, Palo Alto

Delfi Diagnostics

Biotechnology
Health Care
Health Diagnostics
1
$5M12 Aug 2019 United States, Baltimore
News
Neuspera Medical Closes $65M Series C Equity Financing
– Neuspera Medical Inc. closed a $65m series C equity financing. – The round was co-led by Vertex Ventures HC and Treo Ventures with participation from returning Series A and Series B investors Action Potential Venture Capital and Windham Venture Partners. – The new funding will be used to conduct the SANS-UUI pivotal clinical study of its miniaturized implantable neuromodulation technology platform for use in subjects with Urinary Urgency Incontinence, a symptom of overactive bladder (OAB). Read more
Upward Health Announces Significant Growth Equity Investment Led by Heritage Group
– Upward Health raised a significant equity financing led by Heritage Group, with participation from existing investors including Noro-Moseley Partners, the Blue Venture Fund and Windham Ventures. – The company partners with health plans, taking on risk and guaranteeing outcomes in both cost and quality across their most complex and high-cost populations. – The company pairs these members with care specialists who form trusted relationships and coordinate all aspects of the members’ care. – Upward Health e... Read more

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Windham Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: